Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020

Go back to Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
Gilead Sciences (NASDAQ: GILD) Delayed: 131.76 +2.45 (1.89%)
Previous Close $129.31    52 Week High $108.63 
Open $131.00    52 Week Low $71.39 
Day High $131.76    P/E 72.80 
Day Low $129.43    EPS $1.81 
Volume 805,549